日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma

FLIPI24:一种用于新诊断滤泡性淋巴瘤的现代预后模型和临床试验富集工具

Maurer, Matthew J; Prochazka, Vit K; El-Galaly, Tarec Christoffer; Flowers, Christopher R; Villa, Diego; Bachy, Emmanuel; Cahn, Elliot J; Fournier, Marguerite; Larson, Melissa C; Dietrich, Caroline E; Jakobsen, Lasse Hjort; Ghesquières, Hervé; Kridel, Robert; Gandhi, Maher K; Cheah, Chan Y; Hawkes, Eliza A; Seymour, John F; Freeman, Ciara L; Clausen, Michael R; Wahlin, Björn E; Friedberg, Jonathan W; Casulo, Carla; Habermann, Thomas M; Wang, Yucai; Nastoupil, Loretta J; de Nully Brown, Peter; Belada, David; Janíková, Andrea; Mocikova, Heidi; Fürst, Tomáš; Feugier, Pierre; Tilly, Hervé; Haioun, Corinne; Davies, Andrew J; Cartron, Guillaume; Burack, Richard; Chihara, Dai; Martin, Peter; Cohen, Jonathon B; Lossos, Izidore S; Kahl, Brad S; Sehn, Laurie H; Smedby, Karin E; Salles, Gilles; Trneny, Marek; Link, Brian K; Morschhauser, Franck; Cerhan, James R

CAR-T Cells: Current Status, Challenges, and Future Prospects

CAR-T细胞:现状、挑战与未来展望

Adly, Aya Sedky; Cartron, Guillaume; Adly, Afnan Sedky; Egea, Jean-Christophe; Dutilleul, Pierre-Yves Collart; Adly, Mahmoud Sedky; Villalba, Martin

Measurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO group

在既往未接受治疗的中危慢性淋巴细胞白血病患者中,以可测量的残余病灶为指导,比较伊布替尼联合维奈克拉与FCR方案的疗效:一项来自FILO组的II期随机试验(ERADIC)。

Quinquenel, Anne; Letestu, Rémi; Le Garff-Tavernier, Magali; Morisset, Stéphane; Subtil, Fabien; Aurran, Thérèse; Laribi, Kamel; Cymbalista, Florence; Lévy, Vincent; Simon, Laurence; Roos-Weil, Damien; Leblond, Véronique; Dilhuydy, Marie-Sarah; Tomowiak, Cécile; Dartigeas, Caroline; Guièze, Romain; Tournilhac, Olivier; Ferrant, Emmanuelle; de Guibert, Sophie; Feugier, Pierre; Merabet, Fatiha; Leprêtre, Stéphane; Carassou, Philippe; Gay, Julie; Hivert, Bénédicte; Fornecker, Luc-Matthieu; Dupuis, Jehan; Molina, Lysiane; Villemagne, Bruno; Cartron, Guillaume; Drenou, Bernard; Mahé, Beatrice; Benbrahim, Omar; Cahu, Xavier; Portois, Christelle; Ysebaert, Loïc; Nguyen-Khac, Florence; Dahmani, Abdelmalek; Quiney, Claire; Rouillé, Valérie; Delmer, Alain; Michallet, Anne-Sophie

Health-related quality of life after second-line axi-cel in transplant-ineligible patients with large B-cell lymphoma

接受二线axi-cel治疗后不适合移植的大B细胞淋巴瘤患者的健康相关生活质量

Charton, Emilie; Anota, Amélie; Bachy, Emmanuel; Cartron, Guillaume; Gros, François-Xavier; Morschhauser, Franck; Oberic, Lucie; Gastinne, Thomas; Feugier, Pierre; Dulery, Remy; Thieblemont, Catherine; Joris, Magalie; Jardin, Fabrice; Choquet, Sylvain; Casasnovas, Olivier; Brisou, Gabriel; Cheminant, Morgane; Bay, Jacques-Olivier; Llamas Gutierrez, Francisco; Portugues, Cédric; Itti, Emmanuel; Palard-Novello, Xavier; Blanc-Durand, Paul; Al Tabaa, Yassine; Bailly, Clément; Laurent, Camille; Lemonnier, François; Houot, Roch

Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry

CAR-T细胞疗法后侵袭性B细胞淋巴瘤晚期治疗失败:来自DESCAR-T注册研究的LYSA研究

Erbella, Federico; Bachy, Emmanuel; Cartron, Guillaume; Gat, Elodie; Manson, Guillaume; Morschhauser, Franck; Gros, Francois-Xavier; Roulin, Louise; Tessoulin, Benoit; Bories, Pierre; Tournilhac, Olivier; Ricard, Laure; Guidez, Stéphanie; Choquet, Sylvain; Casasnovas, Rene-Olivier; Brisou, Gabriel; Campidelli, Arnaud; Castilla-Llorente, Cristina; Jardin, Fabrice; Gyan, Emmanuel; Guffroy, Blandine; Abraham, Julie; Decroocq, Justine; Chauchet, Adrien; Joris, Magalie; Claves, Fabien; Carras, Sylvain; Guillerm, Gaëlle; Loschi, Michaël; Hermine, Olivier; Taguy-Schimidt, Aline; Le Gouill, Steven; Houot, Roch; Di Blasi, Roberta

The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL

MURANO 研究:VenR 治疗复发/难治性 CLL 患者的最终分析和再治疗/交叉亚组研究结果

Kater, Arnon P; Harrup, Rosemary; Kipps, Thomas J; Eichhorst, Barbara; Owen, Carolyn J; Assouline, Sarit; Lamanna, Nicole; Robak, Tadeusz; de la Serna, Javier; Jaeger, Ulrich; Cartron, Guillaume; Montillo, Marco; Mellink, Clemens; Langerak, Anton W; Chyla, Brenda; Popovic, Relja; Jiang, Yanwen; Millen, Rosemary; Lefebure, Marcus; Thadani-Mulero, Maria; Boyer, Michelle; Seymour, John F

Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry

接受抗CD19 CAR-T细胞治疗的复发或难治性原发性纵隔B细胞淋巴瘤患者的预后:CARTHYM研究,一项来自法国国家DESCAR-T注册研究。

Galtier, Jean; Mesguich, Charles; Sesques, Pierre; Dupont, Vivien; Bachy, Emmanuel; Di Blasi, Roberta; Thieblemont, Catherine; Gastinne, Thomas; Cartron, Guillaume; Brisou, Gabriel; Gros, François-Xavier; Decroocq, Justine; Morschhauser, Franck; Rubio, Marie-Thérèse; Drieu La Rochelle, Laurianne; Le Bras, Fabien; Carras, Sylvain; Chauchet, Adrien; Bay, Jacques-Olivier; Joris, Magalie; Loschi, Mickael; Tanguy-Schmidt, Aline; Marquet, Alexandra; Camus, Vincent; Le Gouill, Steven; Houot, Roch; Bouabdallah, Krimo

Outcomes and treatment patterns of patients with primary mediastinal B-cell lymphoma after CAR-T cell therapy failure: A DESCAR-T analysis

CAR-T细胞治疗失败后原发性纵隔B细胞淋巴瘤患者的预后和治疗模式:一项DESCAR-T分析

Galtier, Jean; Sesques, Pierre; Dupont, Vivien; Bachy, Emmanuel; Di Blasi, Roberta; Thieblemont, Catherine; Brisou, Gabriel; Gastinne, Thomas; Cartron, Guillaume; Gros, François-Xavier; Morschhauser, Franck; André, Axel; Bay, Jacques-Olivier; Joris, Magalie; Tanguy-Schmidt, Aline; Demailly, Audrey; Le Gouill, Steven; Houot, Roch; Bouabdallah, Krimo; Camus, Vincent

Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA

抗PD-1疗法治疗结外NK/T细胞淋巴瘤的疗效:来自LYSA研究的匹配队列分析

Marouf, Amira; Chaubard, Sammara; Liévin, Raphaël; Michot, Jean-Marie; Molinari, Nicolas; Rossignol, Julien; Cavalieri, Doriane; Golfier, Camille; Allangba, Olivier; Philippe, Laure; Tessoulin, Benoît; Chauchet, Adrien; Deau, Bénédicte; Oberic, Lucie; Vargaftig, Jacques; Moignet, Aline; Clavert, Aline; Dulery, Rémy; Brisou, Gabriel; Tardy, Stéphanie; Fataccioli, Virginie; Houot, Roch; Casasnovas, René O; Thieblemont, Catherine; Ghesquières, Hervé; Carras, Sylvain; Le Gouill, Steven; Cartron, Guillaume; Ribrag, Vincent; Cheminant, Morgane; Marçais, Ambroise; Suarez, Felipe; Marabelle, Aurélien; Tournilhac, Olivier; Damaj, Gandhi; Gaulard, Philippe; De Leval, Laurence; Lemonnier, François; Bachy, Emmanuel; Chevret, Sylvie; Hermine, Olivier; Couronné, Lucile; Jaccard, Arnaud

The Arming of Natural Killer Cells With Fc-Engineered Monoclonal Antibodies Confers Specificity Against Tumor B Cells

利用Fc工程化单克隆抗体武装自然杀伤细胞,可赋予其对抗肿瘤B细胞的特异性。

Constantinides, Michaël; Coënon, Loïs; Falvo, Paolo; Multrier, Caroline; Lombardi, Davide; Bertolini, Francesco; Martineau, Pierre; Robert, Bruno; Cartron, Guillaume; Villalba, Martin